Related references
Note: Only part of the references are listed.Markers of Polyfunctional SARS-CoV-2 Antibodies in Convalescent Plasma
Harini Natarajan et al.
MBIO (2021)
Alphaherpesvirus Vaccines
Clare Burn Aschner et al.
CURRENT ISSUES IN MOLECULAR BIOLOGY (2021)
Glycoprotein C of Herpes Simplex Virus 1 Shields Glycoprotein B from Antibody Neutralization
Tri Komala Sari et al.
JOURNAL OF VIROLOGY (2020)
A Single-Cycle Glycoprotein D Deletion Viral Vaccine Candidate, ΔgD-2, Elicits Polyfunctional Antibodies That Protect against Ocular Herpes Simplex Virus
Natalie L. M. Ramsey et al.
JOURNAL OF VIROLOGY (2020)
Vaccination Route as a Determinant of Protective Antibody Responses against Herpes Simplex Virus
Clare Burn Aschner et al.
VACCINES (2020)
HVEM signaling promotes protective antibody-dependent cellular cytotoxicity (ADCC) vaccine responses to herpes simplex viruses
Clare Burn Aschner et al.
SCIENCE IMMUNOLOGY (2020)
Survivors of Ebola Virus Disease Develop Polyfunctional Antibody Responses
Bronwyn M. Gunn et al.
JOURNAL OF INFECTIOUS DISEASES (2020)
Meeting report: Initial World Health Organization consultation on herpes simplex virus (HSV) vaccine preferred product characteristics, March 2017
Sami L. Gottlieb et al.
VACCINE (2019)
Nucleoside-modified mRNA encoding HSV-2 glycoproteins C, D, and E prevents clinical and subclinical genital herpes
Sita Awasthi et al.
SCIENCE IMMUNOLOGY (2019)
Murine Model of Maternal Immunization Demonstrates Protective Role for Antibodies That Mediate Antibody-Dependent Cellular Cytotoxicity in Protecting Neonates From Herpes Simplex Virus Type 1 and Type 2
Carol M Kao et al.
JOURNAL OF INFECTIOUS DISEASES (2019)
Complement enhances in vitro neutralizing potency of antibodies to human cytomegalovirus glycoprotein B (gB) and immune sera induced by gB/MF59 vaccination
Fengsheng Li et al.
NPJ VACCINES (2017)
Polyfunctional HIV-Specific Antibody Responses Are Associated with Spontaneous HIV Control
Margaret E. Ackerman et al.
PLOS PATHOGENS (2016)
HSV-2 ΔgD elicits FcγR-effector antibodies that protect against clinical isolates
Christopher D. Petro et al.
JCI INSIGHT (2016)
Patient-Specific Neutralizing Antibody Responses to Herpes Simplex Virus Are Attributed to Epitopes on gD, gB, or Both and Can Be Type Specific
Tina M. Cairns et al.
JOURNAL OF VIROLOGY (2015)
Herpes simplex type 2 virus deleted in glycoprotein D protects against vaginal, skin and neural disease
Christopher Petro et al.
ELIFE (2015)
Global Estimates of Prevalent and Incident Herpes Simplex Virus Type 2 Infections in 2012
Katharine J. Looker et al.
PLOS ONE (2015)
Global and Regional Estimates of Prevalent and Incident Herpes Simplex Virus Type 1 Infections in 2012
Katharine J. Looker et al.
PLOS ONE (2015)
Correlate of Immune Protection Against HSV-1 Genital Disease in Vaccinated Women
Robert B. Belshe et al.
JOURNAL OF INFECTIOUS DISEASES (2014)
Blocking Herpes Simplex Virus 2 Glycoprotein E Immune Evasion as an Approach To Enhance Efficacy of a Trivalent Subunit Antigen Vaccine for Genital Herpes
Sita Awasthi et al.
JOURNAL OF VIROLOGY (2014)
HSV activates Akt to trigger calcium release and promote viral entry: novel candidate target for treatment and suppression
Natalia Cheshenko et al.
FASEB JOURNAL (2013)
Griffithsin Protects Mice from Genital Herpes by Preventing Cell-to-Cell Spread
Briana Nixon et al.
JOURNAL OF VIROLOGY (2013)
Efficacy Results of a Trial of a Herpes Simplex Vaccine
Robert B. Belshe et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Bridging the Gap between Preclinical and Clinical Microbicide Trials: Blind Evaluation of Candidate Gels in Murine Models of Efficacy and Safety
Theodore J. Segarra et al.
PLOS ONE (2011)
Complement Protein C1q Reduces the Stoichiometric Threshold for Antibody-Mediated Neutralization of West Nile Virus
Erin Mehlhop et al.
CELL HOST & MICROBE (2009)
Genital Herpes Has Played a More Important Role than Any Other Sexually Transmitted Infection in Driving HIV Prevalence in Africa
Laith J. Abu-Raddad et al.
PLOS ONE (2008)
Safety and immunogenicity of glycoprotein D-adjuvant genital herpes vaccine
DI Bernstein et al.
CLINICAL INFECTIOUS DISEASES (2005)
Glycoprotein-D-adjuvant vaccine to prevent genital herpes
LR Stanberry et al.
NEW ENGLAND JOURNAL OF MEDICINE (2002)
Comparison of in vitro antibody-targeted cytotoxicity using mouse, rat and human effectors
I Bergman et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2000)
Share Paper
